Bristol-Myers Squibb Financial Statements
Bristol-Myers Squibb Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Bristol-Myers Squibb Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 19,348.0 | 17,914.0 | 19,207.0 |
| Gross Profit ($ mil.) | 13,130.0 | 11,958.0 | 13,279.0 |
| Operating Income ($ mil.) | 3,374.0 | 2,460.0 | 4,182.0 |
| Total Net Income ($ mil.) | 2,165.0 | 1,585.0 | 3,000.0 |
| Diluted EPS (Net Income) | 1.09 | 0.81 | 1.52 |
Bristol-Myers Squibb Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,913.0 | 5,181.0 | 4,894.0 |
| Gross Profit ($ mil.) | 3,330.0 | 3,524.0 | 3,239.0 |
| Operating Income ($ mil.) | 968.0 | 1,165.0 | 249.0 |
| Total Net Income ($ mil.) | 764.0 | 661.0 | (89.0) |
| Diluted EPS (Net Income) | 0.39 | 0.33 | (0.05) |
Bristol-Myers Squibb Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.02 | 2.84 | 1.29 |
| Price/Earnings Ratio | 18.40 | 12.30 | 13.49 |
| Price/Book Ratio | 3.75 | 2.24 | 1.23 |
| Price/Cash Flow Ratio | 12.46 | 10.70 | 8.08 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Bristol-Myers Squibb Financial Ratios
Bristol-Myers Squibb Competitive Intelligence
| Merck | Novartis | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 24,197.7 | 38,947.0 | 48,418.0 |
| Employees | 59,800 | 98,200 | 86,600 |
| Market Cap ($ mil.) | 68,087.8 | -- | 128,078.9 |
Competitive Landscape
